Literatur
van den Bergh RC, van Casteren NJ, van den Broeck T et al (2016) Role of hormonal treatment inprostate cancer patients with nonmetastatic disease recurrence after local curative treatment: a systematic review. Eur Urol 69:802–820
De Bruycker A, Lambert B, Claeys T et al (2017) Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy. BJU Int 120:815–821
Gomez DR, Blumenschein GR, Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17:1672–1682
Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10
Ost P, Bossi A, Decaestecker K et al (2015) Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol 67:852–863
Ost P, Reynders D, Decaestecker K et al (2017) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol. https://doi.org/10.1200/JCO.2017.75.485
Parker WP, Davis BJ, Park SS et al (2017) Identification of site-specific recurrence following primary radiation therapy for prostate cancer using C‑11choline positron emission tomography/computed tomography: a nomogram for predicting extrapelvic disease. Eur Urol 71:340–348
Sobol I, Zaid HB, Haloi R et al (2017) Contemporary mapping of post-prostatectomy prostate cancer relapse with (11)C-choline positron emission tomography and multiparametric magnetic resonance imaging. J Urol 197:129–134
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Dunst und R. Baumann geben an, dass kein Interessenkonflikt besteht.
Additional information
Originalpublikation
Ost P, Reynders D, Decaestecker K et al (2017) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol. https://doi.org/10.1200/JCO.2017.75.4853
Rights and permissions
About this article
Cite this article
Dunst, J., Baumann, R. Lokale Metastasentherapie bei oligometatasierten Karzinomen. Strahlenther Onkol 194, 465–467 (2018). https://doi.org/10.1007/s00066-018-1284-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-018-1284-4